About (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride
(2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride (PubChem CID 155518886) has the molecular formula C34H43ClFN5O3
and a molecular weight of 624.20 g/mol. Its IUPAC name is (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride.
Molecular Properties
| Compound Name | (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride |
| PubChem CID | 155518886 |
| Molecular Formula | C34H43ClFN5O3 |
| Molecular Weight | 624.20 g/mol |
| Exact Mass | 623.30 |
| IUPAC Name | (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride |
| SMILES | CC(C)CCOc1ccccc1-c1ccccc1OCc1cn([C@H](CCCCN)C(=O)NCCc2ccc(F)cc2)nn1.Cl |
| InChI | InChI=1S/C34H42FN5O3.ClH/c1-25(2)19-22-42-32-12-5-3-9-29(32)30-10-4-6-13-33(30)43-24-28-23-40(39-38-28)31(11-7-8-20-36)34(41)37-21-18-26-14-16-27(35)17-15-26;/h3-6,9-10,12-17,23,25,31H,7-8,11,18-22,24,36H2,1-2H3,(H,37,41);1H/t31-;/m1./s1 |
| InChIKey | MZBSJHWLMVDUDO-JSSVAETHSA-N |
| XLogP | 6.54 |
| TPSA | 104.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 624.20 |
| LogP ≤ 5 | 6.54 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride?
The IUPAC name of (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride (CID 155518886) is (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride.
What is the SMILES notation for (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride?
The canonical SMILES for (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride is CC(C)CCOc1ccccc1-c1ccccc1OCc1cn([C@H](CCCCN)C(=O)NCCc2ccc(F)cc2)nn1.Cl.
What is the InChIKey of (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride?
The InChIKey is MZBSJHWLMVDUDO-JSSVAETHSA-N. The full InChI is InChI=1S/C34H42FN5O3.ClH/c1-25(2)19-22-42-32-12-5-3-9-29(32)30-10-4-6-13-33(30)43-24-28-23-40(39-38-28)31(11-7-8-20-36)34(41)37-21-18-26-14-16-27(35)17-15-26;/h3-6,9-10,12-17,23,25,31H,7-8,11,18-22,24,36H2,1-2H3,(H,37,41);1H/t31-;/m1./s1.
What are the key properties of (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride?
(2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride has a molecular weight of 624.20 g/mol, XLogP of 6.54, 17 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-6-amino-N-[2-(4-fluorophenyl)ethyl]-2-[4-[[2-[2-(3-methylbutoxy)phenyl]phenoxy]methyl]triazol-1-yl]hexanamide;hydrochloride is sourced from PubChem (CID 155518886), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).